The high prevalence of cardiovascular disease (CVD) in the Hispanic population of the United States, together with low rates of health insurance coverage, suggest a potential cardiovascular health crisis. The objective of Project HEART (Health Education Awareness Research Team) was to promote behavior changes to decrease CVD risk factors in a high-risk Hispanic border population.
Project HEART took place from 2005 through 2008 as a randomized community trial with a community-based participatory research framework using
Participants in the experimental group showed more awareness of CVD risk factors, more confidence in the control of these factors, and improved dietary habits (ie, lower salt and cholesterol intake, better weight-control practices) compared with the control group. Total cholesterol was 3% lower in the experimental than in the control participants, and non–high-density lipoprotein cholesterol and low-density lipoprotein cholesterol were both 5% lower.
The HEART trial suggests that community health education using
Heart disease and stroke are the leading causes of death among Hispanics, including those of Mexican origin (
The high prevalence of CVD risk factors among Hispanics, together with the lack of health insurance coverage for screening and limited public health capacity for prevention and control, suggests a looming Hispanic cardiovascular health crisis (
Few randomized controlled trials have studied the use of
This article describes Project HEART (Health Education Awareness Research Team), which was based on
Project HEART was the first phase (2005-2008) of a CBPR initiative and included 1) 3 academic partners: the University of Texas at El Paso, the University of Texas at Houston Health Science Center School of Public Health, El Paso Regional Campus, and El Paso Community College; 2) a community clinic, Centro San Vicente, that provides services to residents of El Paso who do not have adequate health insurance coverage; 3)
During the first year of the project (September 2005-August 2006), a variety of CBPR strategies were used for Project HEART to engage different constituencies and partners in a dialogue about how to decrease the prevalence of CVD risk factors in Hispanics (most of Mexican origin) who live in El Paso, Texas. They included a
Recruitment of participants for the 4-month intervention started in the fall of 2006. Ten US Census tracts in the 79915 zip code (area of the Lower Valley of El Paso selected by the community advisory council) were randomly assigned to either the experimental or the control group. The Lower Valley area is characterized by a larger percentage of residents of Hispanic descent (94%) and lower mean educational attainment than the rest of El Paso. Only approximately 5% of residents have an education beyond high school, the median annual family income is approximately $26,000, and approximately 26% of families live below the federal poverty threshold (
Blocks within each census tract were assigned to recruiters (graduate students and employees of Centro San Vicente clinic), who were unaware whether the census tract was assigned to the experimental or control group. Using a screening instrument designed for the project (
The experimental group was assigned to a series of 8 health classes using the
Height, weight, waist circumference, blood pressure, hemoglobin A1c (HbA1c), and lipids were measured for all participants at baseline and 4 months after the intervention. Body mass index, metabolic syndrome, and Framingham 10-year CVD risk factor scores were also calculated by using standard protocols (
Finally, the My Habits Scale previously tested in several
Differences between baseline demographic variables for the experimental and control groups were tested by using χ2 tests for frequencies or independent-samples
Of the 1,395 people who were asked about their willingness to answer the screening questions, 993 (71%) agreed. Of these, 568 were eligible for the study and 407 (71%) agreed to participate. Of the 407 who agreed to participate, 328 (81%) were measured at baseline (192 in the experimental group and 136 in the control group) and 284 were measured at follow-up (158 in the experimental group and 126 in the control group), a retention rate of 87%.
At baseline, more than 70% of participants were female, and the mean age was 54 years (
For the experimental group, significant decreases were observed at 4-month follow-up for weight, low-density lipoprotein (LDL) cholesterol, total cholesterol, non–high-density lipoprotein (HDL) cholesterol, systolic blood pressure, and diastolic blood pressure (
Only 1 clinical indicator, diastolic blood pressure, was significantly different between the 2 groups after controlling for baseline values and confounders (
Project HEART successfully implemented the 4-month intervention in an underserved Hispanic community in the Lower Valley of El Paso, Texas. The 4-month educational intervention using
The improvements in self-reported heart-healthy behaviors seen in the experimental group are comparable to the results of similar interventions that have used the
To our knowledge, this is the first randomized community trial using
In examining unadjusted and adjusted differences in clinical indicators after the intervention, and taking into consideration the demographic characteristics of the sample participants, several trends emerged. First, some effects, particularly on blood pressure, were seen regardless of the group assignment. However, on the basis of unadjusted results, the experimental group had more risk reduction than the control group for many of the clinical indicators. Second, the unadjusted paired-test values suggest a positive trend for the effects of the
Thus, although participation in the 4-month education component improved nutrition behaviors and awareness of CVD risk factors, both experimental and control groups showed some positive changes in clinical indicators. Several explanations are possible. Changes in dietary intake and behavior may have occurred, but the study was not long enough for the changed behavior to be reflected in differences in clinical indicators between the 2 groups. In addition, self-reported intake and awareness may not be as strongly associated with measured clinical indicators as expected.
This study has several limitations. It was conceptualized as part of a CBPR effort among several community and university partners, and these partners wanted to provide clinical results to all participants regardless of group assignment. Both groups received feedback from the study's principal and co-principal investigators (LS, HB) at baseline, which was a powerful incentive for participants regardless of group assignment. Thus, receiving baseline measurements and interacting with the project staff may have been an intervention in itself.
The study randomized participants into intervention and control groups, and this strategy worked well for age, sex, marital status, income, health insurance status, and family history of CVD. Despite randomization, however, some differences in demographic variables were present at baseline. To be conservative in our estimates, the variables that differed between groups at baseline were included as covariates. As a result, the power of the intervention may have been reduced, limiting the ability to find differences in clinical indicators.
The results of this randomized community trial suggest that community health education using
This research was supported by National Institutes of Health/National Center for Minority Health Disparities grant no. R24 MD0001785-01.
Do you plan to move out of town in the next 6 months?
Yes
No
Don't know
Refused
What is your age?
Are you pregnant or plan to become pregnant in the next 6 months?
Yes
No
Don't know
Refused
Are you Hispanic or Latino?
Yes
No
Don't know
Refused
Have you ever been told by a doctor that you have any of the following risk factors?
High blood pressure
Yes
No
Don't know
High cholesterol
Yes
No
Don't know
Diabetes
Yes
No
Don't know
Overweight
Yes
No
Don't know
Do you smoke cigarettes?
Yes
No
Do you have a history of heart disease?
Yes
No
Don't know
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the US Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above. URLs for nonfederal organizations are provided solely as a service to our users. URLs do not constitute an endorsement of any organization by CDC or the federal government, and none should be inferred. CDC is not responsible for the content of Web pages found at these URLs.
Characteristics of Participants in Project HEART, El Paso, Texas, 2005-2008
| Control Group (n = 136) | Experimental Group (n = 192) | ||
|---|---|---|---|
| 90 (68) | 138 (75) | .20 | |
| 54.0 (13.2) | 53.5 (13.4) | .83 | |
| Mexico | 61 (48) | 112 (60) | .03 |
| United States | 66 (52) | 75 (40) | |
| 41.6 (18.6) | 37.1 (18.7) | .03 | |
| English only | 8 (6) | 4 (2) | .02 |
| Spanish only | 35 (26) | 76 (40) | |
| Both English and Spanish | 90 (67) | 103 (58) | |
| 10.7 (3.3) | 9.7 (3.5) | .01 | |
| 47 (35) | 58 (30) | .43 | |
| Very well off or well off | 19 (14) | 12 (6) | .02 |
| Getting by | 86 (64) | 115 (61) | |
| Not getting by | 30 (22) | 61 (32) | |
| <$10,000 | 50 (38) | 71 (38) | .91 |
| $10,000 to <$20,000 | 48 (35) | 68 (37) | |
| ≥$20,000 | 37 (27) | 47 (25) | |
| 52 (39) | 84 (44) | .28 | |
| 30 (22) | 58 (30) | .09 | |
| 59 (45) | 91 (51) | .34 | |
| 87 (67) | 121 (67) | .52 | |
| Married/living with a partner | 92 (68) | 119 (63) | .47 |
| Widowed/separated/divorced | 33 (24) | 48 (26) | |
| Never married | 10 (7) | 21 (11) | |
| 3.3 (1.6) | 3.4 (1.8) | .53 | |
Abbreviations: HEART, Health Education Awareness Research Team; SD, standard deviation; CVD, cardiovascular disease.
All values are reported as no. (%) unless otherwise indicated.
Values for each question may not correspond to the group total because of missing responses. Percentages may not total 100 because of rounding.
Unadjusted Differences From Baseline to Follow-Up for Cardiovascular Disease Clinical Indicators, Project HEART, El Paso, Texas, 2005-2008
| Clinical Indicator | Control Group (n = 136) | Experimental Group (n = 192) | ||||
|---|---|---|---|---|---|---|
| Baseline | 4-Month Follow-Up | Baseline | 4-Month Follow-Up | |||
| Body mass index, kg/m2 | 31.1 (6.4) | 31.2 (6.5) | .28 | 31.7 (6.8) | 31.6 (6.7) | .34 |
| Weight, lb | 183.1 (42.5) | 183.0 (43.0) | .84 | 181.8 (39.1) | 180.5 (40.0) | .01 |
| Waist circumference, in | 40.2 (6.0) | 41.0 (5.7) | .01 | 40.6 (5.8) | 40.7 (5.9) | .49 |
| Framingham risk score | 14.3 (11.9) | 9.3 (7.0) | <.001 | 15.5 (13.2) | 10.8 (7.9) | <.001 |
| Metabolic syndrome, mean no. of risk factors | 2.4 (1.3) | 2.6 (1.3) | .01 | 2.4 (1.2) | 2.7 (1.2) | <.001 |
| LDL cholesterol, mg/dL | 120.2 (31.9) | 119.8 (33.6) | .86 | 127.6 (36.2) | 121.3 (38.0) | .01 |
| HDL cholesterol, mg/dL | 42.6 (10.7) | 41.5 (11.2) | .11 | 40.6 (11.2) | 40.6 (10.0) | .97 |
| Total cholesterol, mg/dL | 190.5 (38.5) | 190.5 (42.4) | .99 | 197.5 (48.5) | 192.3 (54.5) | .03 |
| Non-HDL cholesterol, mg/dL | 147.9 (37.7) | 148.9 (42.9) | .69 | 155.1 (41.5) | 149.3 (43.1) | .01 |
| Triglyceride level, mg/dL | 139.1 (82.8) | 139.2 (91.7) | .98 | 134.7 (71.5) | 140.9 (77.5) | .21 |
| Fasting blood glucose, mg/dL | 95.3 (31.7) | 99.8 (40.7) | .09 | 101.5 (40.3) | 105.2 (44.3) | .10 |
| HbA1c, % | 6.3 (1.3) | 6.5 (1.3) | .01 | 6.6 (1.5) | 6.6 (1.5) | .83 |
| Systolic blood pressure, mm Hg | 141.4 (20.5) | 132.6 (17.5) | <.001 | 137.2 (21.8) | 131.9 (19.2) | <.001 |
| Diastolic blood pressure, mm Hg | 89.4 (16.3) | 78.3 (10.8) | <.001 | 80.0 (10.9) | 77.6 (9.4) | .01 |
| Smoking | 30 | 21 | .09 | 27 | 19 | .07 |
| Diabetes | 30 | 34 | .50 | 35 | 40 | .32 |
| Systolic hypertension | 45 | 29 | .01 | 37 | 29 | .11 |
| Systolic prehypertension | 40 | 45 | .40 | 36 | 41 | .32 |
| Diastolic hypertension | 41 | 16 | <.001 | 21 | 10 | .01 |
| Diastolic prehypertension | 28 | 24 | .46 | 28 | 25 | .55 |
| Taking hypertension medication | 41 | 40 | .78 | 42 | 45 | .59 |
| Taking lipid-lowering medication | 27 | 29 | .63 | 29 | 35 | .28 |
| Taking diabetes medication | 26 | 22 | .52 | 29 | 30 | .79 |
Abbreviations: HEART, Health Education Awareness Research Team; SD, standard deviation; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HbA1c, hemoglobin A1c.
Framingham score based on age, LDL cholesterol, HDL cholesterol, smoking status, diabetes diagnosis (self-report, HbA1c >7%, or fasting glucose >126 mg/dL).
Significantly different from control at baseline,
Diabetes defined as HbA1c >7%, fasting blood glucose >126 mg/dL, or self-report; systolic hypertension defined as >140 mm Hg and prehypertension defined as >120 mm Hg; diastolic hypertension defined as >90 mm Hg and prehypertension defined as >80 mm Hg.
All variables regarding medication intake are self-reported.
Adjusted Postintervention Differences at Follow-Up for Cardiovascular Disease Clinical Indicators, Project HEART, El Paso, Texas, 2005-2008
| Clinical Indicator | Control Group 4-Month Follow-Up | Experimental Group 4-Month Follow-Up | |
|---|---|---|---|
| Body mass index, kg/m2 | 31.3 (6.7) | 31.1 (6.3) | .28 |
| Weight, lb | 181.1 (44.2) | 180.5 (37.5) | .44 |
| Waist circumference, in | 41.0 (5.9) | 40.4 (5.7) | .09 |
| Framingham risk score | 9.5 (6.7) | 10.4 (7.8) | .26 |
| Metabolic syndrome, mean no. of risk factors | 2.6 (1.2) | 2.7 (1.2) | .32 |
| LDL cholesterol, mg/dL | 123.0 (33.8) | 118.6 (37.8) | .20 |
| HDL cholesterol, mg/dL | 41.5 (11.2) | 41.6 (10.2) | .98 |
| Total cholesterol, mg/dL | 195.2 (42.7) | 189.5 (54.5) | .16 |
| Non-HDL cholesterol, mg/dL | 152.4 (43.4) | 146.3 (42.3) | .10 |
| Triglyceride level, mg/dL | 139.3 (94.5) | 143.6 (78.6) | .64 |
| Fasting blood glucose, mg/dL | 102.7 (42.2) | 101.9 (39.8) | .80 |
| HbA1c, % | 6.6 (1.4) | 6.5 (1.4) | .09 |
| Systolic blood pressure, mm Hg | 130.5 (16.7) | 132.6 (19.4) | .20 |
| Diastolic blood pressure, mm Hg | 75.5 (10.6) | 79.8 (9.3) | <.001 |
Abbreviations: HEART, Health Education Awareness Research Team; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HbA1c, hemoglobin A1c.
Parenthetical values represent the standard deviations.
Between-groups analysis of covariance for the postintervention follow-up values were adjusted for baseline value, self-reported birthplace, language chosen for baseline survey, years of residence in United States, educational attainment, and financial status.
Framingham score based on age, LDL and HDL cholesterol levels, smoking status, diabetes diagnosis (self-report, HbA1c >7%, or fasting blood glucose >126 mg/dL).
Adjusted Postintervention Differences at Follow-Up for Nutrition-Related Behaviors and Health Beliefs, Project HEART, El Paso, Texas, 2005-2008
| Behavior/Belief Indicator | Control Group 4-Month Follow-Up (n = 126) | Experimental Group 4-Month Follow-Up (n = 158) | |
|---|---|---|---|
| Weight-control practices | 1.9 (0.6) | 2.0 (0.6) | .01 |
| Salt intake | 1.8 (0.5) | 2.0 (0.5) | <.001 |
| Cholesterol and fat intake | 1.7 (0.6) | 1.9 (0.7) | .01 |
| Perceived severity | 3.6 (0.5) | 3.6 (0.4) | .33 |
| Perceived benefits | 3.6 (0.5) | 3.7 (0.4) | .01 |
| Perceived susceptibility | 3.4 (0.5) | 3.5 (0.4) | .01 |
| Self-efficacy | 3.3 (0.5) | 3.4 (0.4) | .13 |
Abbreviation: HEART, Health Education Awareness Research Team.
Values indicate responses on a Likert-type scale of 1 to 4, followed by the standard deviation in parentheses.
Between-groups analysis of covariance for the postintervention values were adjusted for baseline value, self-reported birthplace, language chosen for baseline survey, years of residence in United States, educational attainment, and financial status.
Measured with My Habits Behavioral Self-Reported Scales (
Measured with a questionnaire indicating strongly disagree to strongly agree or not at all confident to very confident for self-efficacy.